Alpha Cognition (ACOG) Competitors

Benitec Biopharma (NASDAQ:BNTC) and Alpha Cognition (NASDAQ:ACOG) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, community ranking, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Do insiders & institutionals have more ownership in BNTC or ACOG?

52.2% of Benitec Biopharma shares are owned by institutional investors. 1.3% of Benitec Biopharma shares are owned by insiders. Comparatively, 31.5% of Alpha Cognition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in BNTC or ACOG?

Benitec Biopharma received 195 more outperform votes than Alpha Cognition when rated by MarketBeat users. However, 66.67% of users gave Alpha Cognition an outperform vote while only 65.67% of users gave Benitec Biopharma an outperform vote.

Company	Underperform	Outperform
Benitec Biopharma	Outperform Votes 197 65.67%	Underperform Votes 103 34.33%
Alpha Cognition	Outperform Votes 2 66.67%	Underperform Votes 1 33.33%

Is BNTC or ACOG more profitable?

Alpha Cognition's return on equity of 0.00% beat Benitec Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Benitec Biopharma	N/A	-44.61%	-41.25%
Alpha Cognition	N/A	N/A	-344.17%

Which has more risk & volatility, BNTC or ACOG?

Benitec Biopharma has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500. Comparatively, Alpha Cognition has a beta of 2.5, indicating that its share price is 150% more volatile than the S&P 500.

Does the media favor BNTC or ACOG?

In the previous week, Alpha Cognition had 1 more articles in the media than Benitec Biopharma. MarketBeat recorded 4 mentions for Alpha Cognition and 3 mentions for Benitec Biopharma. Benitec Biopharma's average media sentiment score of 1.44 beat Alpha Cognition's score of 1.35 indicating that Benitec Biopharma is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Benitec Biopharma	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Cognition	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer BNTC or ACOG?

Benitec Biopharma currently has a consensus price target of $24.71, suggesting a potential upside of 81.86%. Alpha Cognition has a consensus price target of $20.00, suggesting a potential upside of 262.32%. Given Alpha Cognition's higher possible upside, analysts plainly believe Alpha Cognition is more favorable than Benitec Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Benitec Biopharma	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.22
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has preferable earnings & valuation, BNTC or ACOG?

Alpha Cognition has lower revenue, but higher earnings than Benitec Biopharma. Benitec Biopharma is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Benitec Biopharma	$80K	3,983.74	-$21.75M	-$1.51	-9.00
Alpha Cognition	N/A	N/A	-$13.77M	-$1.82	-3.03

Summary

Benitec Biopharma beats Alpha Cognition on 9 of the 17 factors compared between the two stocks.